During the past decade, Arizona Center for Cancer Care-Surprise conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 3 clinical trials were completed, i.e. on average, 30% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Arizona Center for Cancer Care-Surprise" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 5 trials, followed by "NRG Oncology" with 3 trials sponsored, "Radiation Therapy Oncology Group" with 2 trials sponsored, "Candel Therapeutics, Inc." with 1 trials sponsored and "EMD Serono Research & Development Institute, Inc." with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Arizona Center for Cancer Care-Surprise" #1 collaborator was "National Cancer Institute (NCI)" with 11 trials as a collaborator, "Canadian Cancer Trials Group" with 2 trials as a collaborator, "NRG Oncology" with 2 trials as a collaborator, "Astellas Pharma Inc" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 0 different institutions and companies that were collaborators in the rest 10 trials.

According to Clinical.Site data, the most researched conditions in "Arizona Center for Cancer Care-Surprise" are "Prostate Cancer" (3 trials), "Estrogen Receptor Negative" (2 trials), "Progesterone Receptor Negative" (2 trials), "Stage IB Breast Cancer" (2 trials) and "Stage II Breast Cancer" (2 trials). Many other conditions were trialed in "Arizona Center for Cancer Care-Surprise" in a lesser frequency.

Most popular intervention types in "Arizona Center for Cancer Care-Surprise" are "Drug" (8 trials), "Radiation" (7 trials), "Other" (5 trials), "Procedure" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Carboplatin" (2 trials), "Paclitaxel" (2 trials), "Quality-of-Life Assessment" (2 trials) and "Questionnaire Administration" (2 trials). Other intervention names were less common.

The vast majority of trials in "Arizona Center for Cancer Care-Surprise" are 6 trials for "Male" genders, 5 trials for "All" genders and 4 trials for "Female" genders.

Currently, there are NaN active trials in "Arizona Center for Cancer Care-Surprise". undefined are not yet recruiting, 3 are recruiting, 8 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Arizona Center for Cancer Care-Surprise, 1 suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Arizona Center for Cancer Care-Surprise, 0 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 9 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".